Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $47.3200 (-2.87%) ($47.3200 - $47.3200) on Tue. Feb. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.38% (three month average) | RSI | 44 | Latest Price | $47.3200(-2.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.7% a day on average for past five trading days. | Weekly Trend | HALO declines -0.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.19% in a week (0% probabilities). VIXM(-31%) VXX(-13%) UUP(-13%) IGOV(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.19% (StdDev 2.38%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $48.79 | 5 Day Moving Average | $48.61(-2.65%) | 10 Day Moving Average | $49.14(-3.7%) | 20 Day Moving Average | $48.79(-3.01%) | To recent high | -6.2% | To recent low | 21% | Market Cap | $6.467b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |